AI-Driven Early Detection of Skin Cancer

Recruiting now

Conditions studied: Skin Cancer Melanoma

In brief

This study evaluates the feasibility and accuracy of an AI-powered mobile platform (NuvanaDx) for early detection of skin cancer, including melanoma, using smartphone-based imaging. The platform is designed to improve access to early diagnosis, reduce waiting times, and support triage into appropriate care pathways.

Key facts

Study ID

NCT07144306

Run by

Nuvana Healthcare LTD

People needed

100

Starts

2025-10-01

Expected to finish

2026-01-01

Last updated by the study team

2025-09-26

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adults (≥18 years) presenting with skin lesions suspicious for malignancy.
• Ability to provide informed consent.

You may not qualify if…

• Inability to provide informed consent.
• Poor-quality images unsuitable for AI analysis.

Where it is running

• Nuvana Healthcare Ltd — London, United Kingdom (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.